000			01659 a2200445 4500
005			20250515135000.0
264		0	_c20091013
008			200910s 0 0 eng d
022			_a1468-3083
024	7		_a10.1111/j.1468-3083.2008.03003.x _2doi
040			_aNLM _beng _cNLM
100	1		_aLopez, V
245	0	0	_aFollicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect. _h[electronic resource]
260			_bJournal of the European Academy of Dermatology and Venereology : JEADV _cAug 2009
300			_a959-60 p. _bdigital
500			_aPublication Type: Case Reports; Letter
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aBenzenesulfonates _xadverse effects
650	0	4	_aHumans
650	0	4	_aHyperplasia _xchemically induced
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aNitrosourea Compounds _xtherapeutic use
650	0	4	_aOrganophosphorus Compounds _xtherapeutic use
650	0	4	_aPhenylurea Compounds
650	0	4	_aPyridines _xadverse effects
650	0	4	_aSkin _xpathology
650	0	4	_aSkin Diseases _xchemically induced
650	0	4	_aSkin Neoplasms _xpathology
650	0	4	_aSorafenib
700	1		_aPinazo, I
700	1		_aMarti, N
700	1		_aMonteagudo, C
700	1		_aJorda, E
773	0		_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 23 _gno. 8 _gp. 959-60
856	4	0	_uhttps://doi.org/10.1111/j.1468-3083.2008.03003.x _zAvailable from publisher's website
999			_c18254751 _d18254751